G.L. Rapaccini

1.9k total citations · 1 hit paper
23 papers, 1.5k citations indexed

About

G.L. Rapaccini is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, G.L. Rapaccini has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 10 papers in Hepatology and 6 papers in Genetics. Recurrent topics in G.L. Rapaccini's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Inflammatory Bowel Disease (5 papers). G.L. Rapaccini is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Inflammatory Bowel Disease (5 papers). G.L. Rapaccini collaborates with scholars based in Italy, Japan and Serbia. G.L. Rapaccini's co-authors include Antonio Gasbarrini, Luca Miele, Antonio Grieco, Giovanni Cammarota, Venanzio Valenza, Fabio Maria Vecchio, Germano Perotti, Alessandra Forgione, Chris Day and Massimo Montalto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Hepatology.

In The Last Decade

G.L. Rapaccini

23 papers receiving 1.5k citations

Hit Papers

Increased intestinal permeability and tight junction alte... 2009 2026 2014 2020 2009 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.L. Rapaccini Italy 11 1.1k 551 430 371 339 23 1.5k
M.L. Gabrieli Italy 4 980 0.9× 507 0.9× 424 1.0× 333 0.9× 251 0.7× 7 1.3k
Monika Rau Germany 21 1.1k 1.0× 553 1.0× 240 0.6× 359 1.0× 390 1.2× 44 1.7k
F. Pons‐Romero Spain 21 1.6k 1.4× 374 0.7× 234 0.5× 369 1.0× 934 2.8× 61 2.1k
Felix Grabherr Austria 19 610 0.5× 410 0.7× 212 0.5× 205 0.6× 113 0.3× 35 1.1k
Takefumi Kimura Japan 22 932 0.8× 317 0.6× 122 0.3× 217 0.6× 609 1.8× 102 1.5k
Erol Avşar Türkiye 20 746 0.7× 258 0.5× 161 0.4× 222 0.6× 329 1.0× 40 1.3k
Andriy Myronovych United States 19 598 0.5× 478 0.9× 657 1.5× 258 0.7× 558 1.6× 31 1.9k
Kristine Buchholtz Denmark 11 1.2k 1.0× 314 0.6× 213 0.5× 949 2.6× 357 1.1× 14 1.6k
Oreste Lo Iacono Italy 27 2.1k 1.8× 291 0.5× 123 0.3× 256 0.7× 1.5k 4.4× 60 2.6k
V. Ponti Italy 10 843 0.7× 134 0.2× 167 0.4× 366 1.0× 97 0.3× 15 1.1k

Countries citing papers authored by G.L. Rapaccini

Since Specialization
Citations

This map shows the geographic impact of G.L. Rapaccini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.L. Rapaccini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.L. Rapaccini more than expected).

Fields of papers citing papers by G.L. Rapaccini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.L. Rapaccini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.L. Rapaccini. The network helps show where G.L. Rapaccini may publish in the future.

Co-authorship network of co-authors of G.L. Rapaccini

This figure shows the co-authorship network connecting the top 25 collaborators of G.L. Rapaccini. A scholar is included among the top collaborators of G.L. Rapaccini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.L. Rapaccini. G.L. Rapaccini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irene, Mignini, et al.. (2021). Acute pancreatitis and parathyroid carcinoma: a case report and literature review. SHILAP Revista de lepidopterología. 3 indexed citations
2.
Iezzi, Roberto, Maurizio Pompili, Emanuele Rinninella, et al.. (2018). TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib. European Radiology. 29(3). 1285–1292. 27 indexed citations
3.
Ferrari, M., Luca Miele, Luisa Guidi, et al.. (2017). Watery stools and metabolic acidosis. Internal and Emergency Medicine. 12(4). 487–492. 2 indexed citations
4.
Miele, Luca, Cristina Bosetti, Federica Turati, et al.. (2015). Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk. Gastroenterology Research and Practice. 2015. 1–5. 38 indexed citations
5.
Boccia, Stefania, Luca Miele, Nikola Panić, et al.. (2015). The Effect ofCYP, GST,andSULTPolymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma. BioMed Research International. 2015. 1–7. 19 indexed citations
6.
Guidi, Luisa, Manuela Marzo, Gianluca Andrisani, et al.. (2014). Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. Digestive and Liver Disease. 46(11). 974–979. 71 indexed citations
7.
Miele, Luca, Valentina Dall’Armi, Consuelo Cefalo, et al.. (2014). A case–control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease. Genes & Nutrition. 9(2). 383–383. 41 indexed citations
8.
Guidi, Luisa, Manuela Marzo, Carla Felice, et al.. (2013). P214 Faecal calprotectin assay after induction with anti-TNF alpha agents in IBD patients: prediction of clinical response and mucosal healing at one year. Journal of Crohn s and Colitis. 7. S95–S95. 1 indexed citations
9.
Armuzzi, Alessandro, Alfredo Papa, Manuela Marzo, et al.. (2013). P.01.3 LONG TERM SUSTAINABILITY OF MUCOSAL HEALING IN ULCERATIVE COLITIS PATIENTS TREATED WITH INFLIXIMAB. Digestive and Liver Disease. 45. S90–S90. 1 indexed citations
10.
Miele, Luca, Giovanni Cammarota, V. Vero, et al.. (2012). Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. Digestive and Liver Disease. 44(12). 1032–1036. 16 indexed citations
11.
Armuzzi, Alessandro, Carla Felice, Manuela Marzo, et al.. (2012). P.16.15 PREVENTION OF POSTOPERATIVE RECURRENCE WITH AZATHIOPRINE OR ANTI-TNF ALPHA IN PATIENTS WITH CROHN'S DISEASE: A PILOT STUDY. Digestive and Liver Disease. 44. S194–S194. 3 indexed citations
12.
Zocco, Maria Assunta, A. Lupascu, Laura Riccardi, et al.. (2010). 603 DYNAMIC CONTRAST ENHANCED ULTRASOUND IN MONITORING HCC PATIENTS TREATED WITH SORAFENIB: PRELIMINARY RESULTS. Journal of Hepatology. 52. S237–S238. 1 indexed citations
13.
Miele, Luca, Venanzio Valenza, Giuseppe La Torre, et al.. (2009). Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†. Hepatology. 49(6). 1877–1887. 1138 indexed citations breakdown →
14.
Pompili, Maurizio, Fabrizio Pizzolante, Luigi Maria Larocca, et al.. (2005). Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis. Digestive and Liver Disease. 38(5). 352–354. 3 indexed citations
15.
Rapaccini, G.L., Maurizio Pompili, Marcello Covino, et al.. (2004). Contrast‐enhanced power Doppler of the intestinal wall in the evaluation of patients with Crohn disease. Scandinavian Journal of Gastroenterology. 39(2). 188–194. 44 indexed citations
16.
Caminiti, Giuseppe, Maurizio Pompili, Marcello Covino, et al.. (2003). Prognosis of patients with hepatocellular carcinoma (HCC) according to okuda staging system, clip staging system and BCLC staging classification: results of a single italian centre. Journal of Hepatology. 38. 6–6. 3 indexed citations
17.
Rapaccini, G.L., et al.. (2001). Hepatitis C virus infection: other biological fluids than blood may be responsible for intrafamilial spread.. PubMed. 48(37). 193–6. 30 indexed citations
18.
Cedrone, A, Marcello Covino, Maurizio Pompili, et al.. (2001). Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.. PubMed. 47(36). 1654–8. 62 indexed citations
19.
Pompili, Maurizio, G.L. Rapaccini, S. Agnes, et al.. (1999). Doppler ultrasonographic evaluation of the early changes in renal resistive index in cirrhotic patients undergoing liver transplantation.. Journal of Ultrasound in Medicine. 18(7). 497–502. 10 indexed citations
20.
Caturelli, Eugenio, et al.. (1987). Ultrasonography and echo-guided fine-needle biopsy in the diagnosis of focal fatty liver change.. PubMed. 34(4). 137–40. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026